Company News for July 31, 2026

Shares of Mastercard Incorporated ( MA) gained 2.5% after the company reported second-quarter 2026 earnings of $5.04 per share, beating the Zacks Consensus Estimate of $4.77 per share.  Bristol-Myers Squibb Company’s ( BMY) shares increased 2.8% after the company reported second-quarter 2026 earnings of $2.04 per share, surpassing the Zacks Consensus Estimate of $1.59 per share. Shares of Altria Group, Inc. ( MO) plunged 9.2% after the company reported second-quarter 2026 earnings of $1.48 per share, missing the Zacks Consensus Estimate of $1.5 per share.  Regeneron Pharmaceuticals, Inc.’s ( REGN) shares jumped 6.2% after the company reported second-quarter 2026 earnings of $14.29 per share, outpacing the Zacks Consensus Estimate of $10 per share. 

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 
Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report
 
Mastercard Incorporated (MA): Free Stock Analysis Report
 
Bristol Myers Squibb Company (BMY): Free Stock Analysis Report
 
Altria Group, Inc. (MO): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research